Page 13 - JCTR-10-4
P. 13

Tyson et al. | Journal of Clinical and Translational Research 2024; 10(4): 229-236   235
        Consent for Publication                                     Assessing  the  Impact  of  Protocol  Design  Changes  on
                                                                    Clinical Trial Performance. Am J Ther 2008;15:450-7.
          Not applicable.
                                                                    doi: 10.1097/MJT.0b013e31816b9027
        Availability of Data                                   [11]  Richie  A,  Gamble  D,  Tavlarides  A,  Griffin  C.  Trial
                                                                    Complexity and Coordinator Capacity: The Development
          Data  are  available  from  the  corresponding  author  on
        reasonable request.                                         of a Complexity Tool. Clin Res 2019;33: 17-23.
                                                               [12]  Shiely F, Foley J, Stone A, Cobbe E, Browne S, Murphy E,
        References                                                  et  al.  Managing  Clinical  Trials  During  COVID-19:
                                                                    Experience  from  a  Clinical  Research  Facility.  Trials
        [1]   Sun  D,  Gao W,  Hu  H,  Zhou  S. Why  90%  of  Clinical   2021;22:62.
             Drug Development Fails and how to Improve it? Acta      doi: 10.1186/s13063-020-05004-8
             Pharm Sin B 2022;12:3049-62.
             doi: 10.1016/j.apsb.2022.02.002                   [13]  Van Norman GA. Decentralized Clinical Trials. JACC
                                                                    Basic Transl Sci 2021;6:384-7.
        [2]   National Institutes of Health. Trends, Charts, and Maps;
             2023.  Available  from:  https://clinicaltrials.gov/ct2/     doi: 10.1016/j.jacbts.2021.01.011
             resources/trends [Last accessed on 2024 Aug 09].  [14]  Gohar  B,  Larivière  M,  Nowrouzi-Kia  B.  Sickness
        [3]   Miessler J. No End in Sight for Trial Complexity, CSDD   Absence in Healthcare Workers during the COVID-19
                                                                    Pandemic. Occup Med (Lond) 2020;70:338-42.
             Report  Reveals.  CenterWatch;  2022.  Available  from:
             https://cms.centerwatch.com/articles/25921-no-end-     doi: 10.1093/occmed/kqaa093
             in-sight-for-trial-complexity-csdd-report-reveals  [Last   [15]  Richie A, Gamble D, Tavlarides A, Strok K, Griffin C.
             accessed on 2024 Aug 09].                              Establishing  the  Link  Between  Trial  Complexity  and
        [4]   Brody  AA,  Convery  KA,  Kline  DM,  Fink  RM,       Coordinator Capacity. Clin Res 2020;34:8-16.
             Fischer SM. Transitioning to Remote Recruitment and   [16]  Smuck B, Bettello P, Berghout K, Hanna T, Kowaleski B,
             Intervention:  A  Tale  of  Two  Palliative  Care  Research   Phippard L, et al. Ontario Protocol Assessment Level:
             Studies  Enrolling  Underserved  Populations  during   Clinical  Trial  Complexity  Rating  Tool  for  Workload
             COVID-19. J Pain Symptom Manage 2022;63:151-9.         Planning  in  Oncology  Clinical  Trials.  J  Oncol  Pract
             doi: 10.1016/j.jpainsymman.2021.06.017                 2011;7:80-4.
        [5]   Chino  F,  Zafar  SY.  Financial  Toxicity  and  Equitable      doi: 10.1200/JOP.2010.000051
             Access to Clinical Trials. Am Soc Clin Oncol Educ Book   [17]  Deglise-Hawkinson  J,  Kaufman  DL,  Roessler  B,  Van
             2019;39:11-8.                                          Oyen MP. Access Planning and Resource Coordination
             doi: 10.1200/EDBK_100019                               for  Clinical  Research  Operations.  IISE  Trans
        [6]   Buchanan DA, Goldstein J, Pfalzer AC, Lin Y, Kang H,   2020;52:832-49.
             Claassen  DO.  Empowering  the  Clinical  Research      doi: 10.1080/24725854.2019.1675202
             Coordinator in Academic Medical Centers. Mayo Clin   [18]  Good  MJ,  Lubejko  B,  Humphries  K,  Medders  A.
             Proc Innov Qual Outcomes 2020;5:265-73.                Measuring  Clinical  Trial-Associated  Workload  in  a
             doi: 10.1016/j.mayocpiqo.2020.09.014                   Community Clinical Oncology Program. J Oncol Pract
        [7]   Lorduy  K,  Brown  V,  Rose  S.  Adapting  Productivity   2013;9:211-5.
             Models to Improve Efficiency and Progress in Clinical      doi: 10.1200/JOP.2012.000797
             Research Practice. Clin Res 2020;34: 13-27.       [19]  Morin  DJ.  Use  of  Proxy  Variables  to  Determine  the
        [8]   Speicher LA, Fromell G, Avery S, Brassil D, Carlson L,   Impact of Protocol Complexity on Clinical Research Site
             Stevens E, et al. The Critical Need for Academic Health   Productivity. Ther Innov Regul Sci 2019;53:52-8.
             Centers  to  Assess  the  Training,  Support,  and  Career      doi: 10.1177/2168479018769290
             Development  Requirements  of  Clinical  Research   [20]  Morin  DJ.  Harmonizing  Protocol  Complexity  with
             Coordinators: Recommendations from the Clinical and    Resource Management and Capacity Planning at Clinical
             Translational  Science  Award  Research  Coordinator   Research Sites. Ther Innov Regul Sci 2020;54:978-87.
             Taskforce. Clin Transl Sci 2012;5:470-5.               doi: 10.1007/s43441-020-00120-8
             doi: 10.1111/j.1752-8062.2012.00423.x             [21]  Fabbri  F,  Gentili  G,  Serra  P,  Vertogen  B, Andreis  D,
        [9]   Kassis S, Winkler S, Gianforti MJ, Needler NA. Research   Dall’Agata M, et al. How many Cancer Clinical Trials
             Coordinator  Networks  and  Support  Models  among     can  a  Clinical  Research  Coordinator  Manage?  The
             Academic  Health  Centers  in  the  CTSA  Consortium.   Clinical  Research  Coordinator  Workload  Assessment
             J Clin Transl Sci 2018;1:334-9.                        Tool. JCO Oncol Pract 2021;17:e68-76.
             doi: 10.1017/cts.2017.309                              doi: 10.1200/JOP.19.00386
        [10]  Getz KA, Wenger J, Campo RA, Seguine ES, Kaitin KI.   [22]  Lledo  L,  Johnson  C,  Chew A,  Gilmore  B,  Dengel  K.

                                              DOI: https://doi.org/10.36922/jctr.24.00022
   8   9   10   11   12   13   14   15   16   17   18